J Mirro

1.7k total citations
21 papers, 1.3k citations indexed

About

J Mirro is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, J Mirro has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 14 papers in Public Health, Environmental and Occupational Health and 8 papers in Genetics. Recurrent topics in J Mirro's work include Acute Myeloid Leukemia Research (19 papers), Acute Lymphoblastic Leukemia research (14 papers) and Chronic Lymphocytic Leukemia Research (7 papers). J Mirro is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Acute Lymphoblastic Leukemia research (14 papers) and Chronic Lymphocytic Leukemia Research (7 papers). J Mirro collaborates with scholars based in United States and Germany. J Mirro's co-authors include MJ Schell, Ching‐Hon Pui, Susan L. Melvin, Victor M. Santana, Raymond L. Blakley, David K. Kalwinsky, S Stass, SB Murphy, C-H Pui and SB Murphy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

J Mirro

21 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Mirro United States 18 882 695 346 325 249 21 1.3k
SB Murphy United States 22 1.0k 1.1× 955 1.4× 280 0.8× 282 0.9× 272 1.1× 32 1.6k
FR Davey United States 14 1.1k 1.2× 722 1.0× 372 1.1× 391 1.2× 227 0.9× 32 1.6k
B Lange United States 14 574 0.7× 388 0.6× 321 0.9× 165 0.5× 289 1.2× 17 1.2k
MJ Schell United States 14 636 0.7× 535 0.8× 184 0.5× 191 0.6× 100 0.4× 17 1000
GK Rivera United States 24 1.2k 1.3× 1.3k 1.9× 368 1.1× 244 0.8× 176 0.7× 41 1.9k
SE Sallan United States 11 609 0.7× 775 1.1× 322 0.9× 218 0.7× 114 0.5× 14 1.4k
GV Dahl United States 12 614 0.7× 667 1.0× 140 0.4× 143 0.4× 133 0.5× 25 995
RE Sobol United States 11 681 0.8× 699 1.0× 181 0.5× 296 0.9× 171 0.7× 15 1.1k
SC Raimondi United States 15 874 1.0× 733 1.1× 454 1.3× 171 0.5× 87 0.3× 15 1.3k
H. Baurmann Germany 18 757 0.9× 294 0.4× 180 0.5× 170 0.5× 86 0.3× 61 1.2k

Countries citing papers authored by J Mirro

Since Specialization
Citations

This map shows the geographic impact of J Mirro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Mirro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Mirro more than expected).

Fields of papers citing papers by J Mirro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Mirro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Mirro. The network helps show where J Mirro may publish in the future.

Co-authorship network of co-authors of J Mirro

This figure shows the co-authorship network connecting the top 25 collaborators of J Mirro. A scholar is included among the top collaborators of J Mirro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Mirro. J Mirro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neale, Geoffrey, Ching‐Hon Pui, H Mahmoud, et al.. (1994). Molecular evidence for minimal residual bone marrow disease in children with 'isolated' extra-medullary relapse of T-cell acute lymphoblastic leukemia.. PubMed. 8(5). 768–75. 36 indexed citations
2.
Santana, Victor M., J Mirro, Cristin Kearns, et al.. (1992). 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia.. Journal of Clinical Oncology. 10(3). 364–370. 120 indexed citations
3.
Lübbert, Michael, J Mirro, Geoffrey R. Kitchingman, et al.. (1992). Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia.. PubMed. 7(2). 263–8. 34 indexed citations
4.
Santana, Victor M., J Mirro, Franklin C. Harwood, et al.. (1991). A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia.. Journal of Clinical Oncology. 9(3). 416–422. 84 indexed citations
5.
Kalwinsky, David K., Michael J. Schell, J Mirro, et al.. (1990). Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia.. Journal of Clinical Oncology. 8(1). 75–83. 86 indexed citations
6.
Lübbert, Michael, J Mirro, Miller Cw, et al.. (1990). N-ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis. Blood. 75(5). 1163–1169. 4 indexed citations
7.
Pui, CH, F G Behm, Bikramjit Singh, et al.. (1990). Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood. 75(1). 198–202. 102 indexed citations
8.
9.
Raimondi, Susana C., ID Dube, M B Valentine, et al.. (1989). Clinicopathologic manifestations and breakpoints of the t(3;5) in patients with acute nonlymphocytic leukemia.. PubMed. 3(1). 42–7. 62 indexed citations
10.
Pui, Ching‐Hon, David K. Kalwinsky, MJ Schell, et al.. (1988). Acute nonlymphoblastic leukemia in infants: clinical presentation and outcome.. Journal of Clinical Oncology. 6(6). 1008–1013. 41 indexed citations
11.
Goorha, RM, FG Behm, SB Murphy, et al.. (1988). Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity. Blood. 72(2). 579–587. 132 indexed citations
12.
Goorha, Rakesh, Nancy Bunin, J Mirro, et al.. (1987). Provocative pattern of rearrangements of the genes for the gamma and beta chains of the T-cell receptor in human leukemias.. Proceedings of the National Academy of Sciences. 84(13). 4547–4551. 39 indexed citations
13.
Dow, LW, et al.. (1986). Correlation of drug sensitivity in vitro with clinical responses in childhood acute myeloid leukemia. Blood. 68(2). 400–405. 25 indexed citations
14.
Mirro, J, et al.. (1986). Phase I-II study of continuous-infusion high-dose human lymphoblastoid interferon and the in vitro sensitivity of leukemic progenitors in nonlymphocytic leukemia.. PubMed. 70(3). 363–7. 8 indexed citations
15.
Mirro, J, et al.. (1986). Mixed lineage leukemia: the implications for hematopoietic differentiation [letter]. Blood. 68(2). 597–599. 24 indexed citations
16.
Murphy, S B, W. Paul Bowman, Minnie Abromowitch, et al.. (1986). Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.. Journal of Clinical Oncology. 4(12). 1732–1739. 199 indexed citations
17.
Mirro, J, David K. Kalwinsky, John K. Whisnant, et al.. (1985). Coagulopathy induced by continuous infusion of high doses of human lymphoblastoid interferon.. PubMed. 69(3). 315–7. 10 indexed citations
18.
Melvin, Susan L., et al.. (1985). Transient myeloproliferative syndrome in a phenotypically normal infant.. PubMed. 7(1). 79–81. 27 indexed citations
19.
Dahl, GV, Gaston K. Rivera, CH Pui, et al.. (1985). A novel treatment of childhood lymphoblastic non-Hodgkin's lymphoma: early and intermittent use of teniposide plus cytarabine. Blood. 66(5). 1110–1114. 44 indexed citations
20.
Stass, S, et al.. (1984). Lineage switch in acute leukemia. Blood. 64(3). 701–706. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by SB Murphy Breakdown of academic impact, for papers by FR Davey Breakdown of academic impact, for papers by B Lange Breakdown of academic impact, for papers by MJ Schell Breakdown of academic impact, for papers by GK Rivera Breakdown of academic impact, for papers by SE Sallan Breakdown of academic impact, for papers by GV Dahl Breakdown of academic impact, for papers by RE Sobol Breakdown of academic impact, for papers by SC Raimondi Breakdown of academic impact, for papers by H. Baurmann
Rankless by CCL
2026